These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28803207)

  • 1. Phase separation of in situ forming poly (lactide-co-glycolide acid) implants investigated using a hydrogel-based subcutaneous tissue surrogate and UV-vis imaging.
    Sun Y; Jensen H; Petersen NJ; Larsen SW; Østergaard J
    J Pharm Biomed Anal; 2017 Oct; 145():682-691. PubMed ID: 28803207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant monitoring of implant formation and drug release of in situ forming poly (lactide-co-glycolide acid) implants in a hydrogel matrix mimicking the subcutis using UV-vis imaging.
    Sun Y; Jensen H; Petersen NJ; Larsen SW; Østergaard J
    J Pharm Biomed Anal; 2018 Feb; 150():95-106. PubMed ID: 29216591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial Leuprolide Acetate Release from Poly(d,l-lactide-
    Li Z; Mu H; Larsen SW; Jensen H; Østergaard J
    Mol Pharm; 2020 Dec; 17(12):4522-4532. PubMed ID: 33164519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLGA in situ implants formed by phase inversion: critical physicochemical parameters to modulate drug release.
    Parent M; Nouvel C; Koerber M; Sapin A; Maincent P; Boudier A
    J Control Release; 2013 Nov; 172(1):292-304. PubMed ID: 24001947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro gel-based system for characterizing and predicting the long-term performance of PLGA in situ forming implants.
    Li Z; Mu H; Weng Larsen S; Jensen H; Østergaard J
    Int J Pharm; 2021 Nov; 609():121183. PubMed ID: 34653562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
    Desai KG; Mallery SR; Schwendeman SP
    Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable long-acting systems for Radix Ophiopogonis polysaccharide based on mono-PEGylation and in situ formation of a PLGA depot.
    Shi X; Lin X; Zheng X; Feng Y; Shen L
    Int J Nanomedicine; 2014; 9():5555-63. PubMed ID: 25489243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging.
    Solorio L; Olear AM; Hamilton JI; Patel RB; Beiswenger AC; Wallace JE; Zhou H; Exner AA
    Theranostics; 2012; 2(11):1064-77. PubMed ID: 23227123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive in vivo characterization of microclimate pH inside in situ forming PLGA implants using multispectral fluorescence imaging.
    Schädlich A; Kempe S; Mäder K
    J Control Release; 2014 Apr; 179():52-62. PubMed ID: 24503251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-situ forming PLGA implants for intraocular dexamethasone delivery.
    Bode C; Kranz H; Siepmann F; Siepmann J
    Int J Pharm; 2018 Sep; 548(1):337-348. PubMed ID: 29981408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do in situ forming PLG/NMP implants behave similar in vitro and in vivo? A non-invasive and quantitative EPR investigation on the mechanisms of the implant formation process.
    Kempe S; Metz H; Mäder K
    J Control Release; 2008 Sep; 130(3):220-5. PubMed ID: 18611421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel injectable in situ forming poly-DL-lactide and DL-lactide/glycolide implant containing lipospheres for controlled drug delivery.
    Yehia SA; Elshafeey AH; Elsayed I
    J Liposome Res; 2012 Jun; 22(2):128-38. PubMed ID: 22091557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of injection site on in situ implant formation and drug release in vivo.
    Patel RB; Solorio L; Wu H; Krupka T; Exner AA
    J Control Release; 2010 Nov; 147(3):350-8. PubMed ID: 20728486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of poly(D,L-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems.
    Dong WY; Körber M; López Esguerra V; Bodmeier R
    J Control Release; 2006 Oct; 115(2):158-67. PubMed ID: 16963145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S; Janoria KG; Pal D; Mitra AK
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease.
    Xie B; Jin L; Luo Z; Yu J; Shi S; Zhang Z; Shen M; Chen H; Li X; Song Z
    Int J Pharm; 2015 Jul; 490(1-2):375-83. PubMed ID: 26027491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation and in-vitro degradation of polylactide and poly(L-lactide-co-glycolide)].
    Wei Z; Liu L; Zhang M; Yang F; Qi M
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Feb; 25(1):122-6. PubMed ID: 18435272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of poly (lactide-co-glycolide) type and gamma irradiation on the betamethasone acetate release from the in situ forming systems.
    Rafienia M; Emami SH; Mirzadeh H; Mobedi H; Karbasi S
    Curr Drug Deliv; 2009 Apr; 6(2):184-91. PubMed ID: 19450225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of exenatide in poly(D,L-lactide-co-glycolide) solutions: a simplified investigation on the peptide degradation by the polymer.
    Liang R; Zhang R; Li X; Wang A; Chen D; Sun K; Liu W; Li Y
    Eur J Pharm Sci; 2013 Nov; 50(3-4):502-10. PubMed ID: 23994054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive characterization of in situ forming implants using diagnostic ultrasound.
    Solorio L; Babin BM; Patel RB; Mach J; Azar N; Exner AA
    J Control Release; 2010 Apr; 143(2):183-90. PubMed ID: 20060859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.